Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic.
Michael D GeorgeShilpa VenkatachalamShubhasree BanerjeeJoshua F BakerPeter A MerkelKelly GaviganDavid CurtisMaria I DanilaJeffrey R CurtisWilliam Benjamin NowellPublished in: The Journal of rheumatology (2020)
In the early months of the COVID-19 pandemic, patients with RA, PsA, AS, and SLE frequently avoided office visits and laboratory testing. DMARD interruptions commonly occurred without the advice of a physician and were associated with SES, office visits, and telehealth availability, highlighting the need for adequate healthcare access and attention to vulnerable populations during the pandemic.
Keyphrases
- healthcare
- prostate cancer
- systemic lupus erythematosus
- disease activity
- sars cov
- emergency department
- coronavirus disease
- primary care
- rheumatoid arthritis
- multiple sclerosis
- ankylosing spondylitis
- radical prostatectomy
- drug induced
- systemic sclerosis
- idiopathic pulmonary fibrosis
- affordable care act
- genetic diversity
- health insurance